Nu Skin Enterprises, Inc. (NYSE:NUS) was the recipient of unusually large options trading on Wednesday. Traders purchased 3,305 put options on the stock. This is an increase of approximately 2,118% compared to the typical daily volume of 149 put options.
Hedge funds have recently bought and sold shares of the company. Mackay Shields LLC lifted its stake in shares of Nu Skin Enterprises by 79.0% in the 4th quarter. Mackay Shields LLC now owns 79,714 shares of the company’s stock valued at $4,889,000 after purchasing an additional 35,188 shares during the period. Delek Group Ltd. acquired a new stake in Nu Skin Enterprises during the 1st quarter worth $17,859,000. Amalgamated Bank raised its stake in Nu Skin Enterprises by 14.8% during the 4th quarter. Amalgamated Bank now owns 11,484 shares of the company’s stock worth $704,000 after buying an additional 1,483 shares during the period. Squarepoint Ops LLC raised its stake in Nu Skin Enterprises by 55.4% during the 4th quarter. Squarepoint Ops LLC now owns 109,000 shares of the company’s stock worth $6,685,000 after buying an additional 38,844 shares during the period. Finally, QS Investors LLC raised its stake in Nu Skin Enterprises by 147.4% during the 4th quarter. QS Investors LLC now owns 20,855 shares of the company’s stock worth $1,280,000 after buying an additional 12,427 shares during the period. 77.17% of the stock is currently owned by institutional investors.
NUS has been the topic of several research reports. Zacks Investment Research downgraded Inflarx from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. DA Davidson increased their price target on Commerce Bancshares to $62.00 and gave the company a “neutral” rating in a research note on Wednesday. Deutsche Bank downgraded Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price target on the stock. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Stifel Nicolaus set a $99.00 price target on C.H. Robinson Worldwide and gave the company a “hold” rating in a research note on Monday, March 25th. Finally, Bank of America cut their price target on Canopy Growth from $80.00 to $75.00 and set a “buy” rating on the stock in a research note on Wednesday, June 19th. Three analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $55.63.
NUS stock opened at $39.34 on Friday. The company has a fifty day moving average of $47.70. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86. The firm has a market cap of $2.53 billion, a P/E ratio of 11.18, a P/E/G ratio of 1.04 and a beta of 0.74. Nu Skin Enterprises has a twelve month low of $35.03 and a twelve month high of $88.68.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.06. The company had revenue of $623.60 million for the quarter, compared to the consensus estimate of $615.98 million. Nu Skin Enterprises had a return on equity of 26.81% and a net margin of 4.82%. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.79 EPS. Analysts predict that Nu Skin Enterprises will post 3.92 EPS for the current year.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.